Literature DB >> 26459323

Serum IL8 and mRNA level of CD11b in circulating neutrophils are increased in clinically amyopathic dermatomyositis with active interstitial lung disease.

Jing Zou1,2, Jie Chen1, Qingran Yan1, Qiang Guo1, Chunde Bao3.   

Abstract

The objective of this study is to assess serum IL8 and the potential activity of circulating neutrophils on relative messenger RNA (mRNA) levels and their relationship with disease activity in clinically amyopathic dermatomyositis (CADM) associated with interstitial lung disease (ILD). We studied 18 CADM patients and compared them with 18 classic dermatomyositis (DM) patients and 18 healthy control subjects. Serum IL8 level and mRNA expressions of neutrophils (chemokine (C-X-C motif) receptor 1 (CXCR1), cluster of differentiation molecule 11b (CD11b), cluster of differentiation 64 (CD64), myeloid cell leukemia 1 (MCL1), interleukin-18 (IL18)) were detected. The overproduction of serum IL8 level was most significant in the CADM group with active period. The mRNA expressions of CD11b, IL18, and MCL1 were greatly increased in the neutrophils in patients with CADM compared with DM or healthy controls. Up-expressions of CD11b, IL18, and MCL1 were detected in the neutrophils in CADM patients of active period compared with remission period. A positive correlation was found between CD11b mRNA level and high-resolution computed tomography (HRCT) score, in CADM associated with ILD. Serum IL8 level and mRNA levels of CD11b, MCL1, and IL18 in circulating neutrophils are related with the disease activity of CADM-ILD. The mRNA level of CD11b is positively correlated with HRCT score in CADM-ILD.

Entities:  

Keywords:  Amyopathic dermatomyositis; Disease activity; Interstitial; Lung diseases; Neutrophils

Mesh:

Substances:

Year:  2015        PMID: 26459323     DOI: 10.1007/s10067-015-3080-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  44 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Neutrophil activation via beta2 integrins (CD11/CD18): molecular mechanisms and clinical implications.

Authors:  Jürgen Schymeinsky; Attila Mócsai; Barbara Walzog
Journal:  Thromb Haemost       Date:  2007-08       Impact factor: 5.249

3.  Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface.

Authors:  L J Miller; D F Bainton; N Borregaard; T A Springer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.

Authors:  R Repp; T Valerius; A Sendler; M Gramatzki; H Iro; J R Kalden; E Platzer
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

Review 5.  Neutrophil kinetics in health and disease.

Authors:  Charlotte Summers; Sara M Rankin; Alison M Condliffe; Nanak Singh; A Michael Peters; Edwin R Chilvers
Journal:  Trends Immunol       Date:  2010-08       Impact factor: 16.687

6.  Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.

Authors:  F Colotta; F Re; N Polentarutti; S Sozzani; A Mantovani
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

Review 7.  Interleukin 8 and acute lung injury.

Authors:  Timothy Craig Allen; Anna Kurdowska
Journal:  Arch Pathol Lab Med       Date:  2013-06-19       Impact factor: 5.534

8.  Expression and alternative processing of IL-18 in human neutrophils.

Authors:  Susan E Robertson; John D Young; Susan Kitson; Andrew Pitt; Jamie Evans; Jurgen Roes; Denise Karaoglu; Ling Santora; Tariq Ghayur; Foo Y Liew; J Alastair Gracie; Iain B McInnes
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

9.  Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine.

Authors:  Masaru Ando; Eishi Miyazaki; Mari Yamasue; Yukiko Sadamura; Toshihiro Ishii; Ryuichi Takenaka; Takeo Ito; Shin-ichi Nureki; Toshihide Kumamoto
Journal:  Clin Rheumatol       Date:  2010-02-04       Impact factor: 3.650

Review 10.  Chemokines in acute respiratory distress syndrome.

Authors:  Padmam Puneet; Shabbir Moochhala; Madhav Bhatia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-01       Impact factor: 5.464

View more
  7 in total

Review 1.  Update on outcome assessment in myositis.

Authors:  Lisa G Rider; Rohit Aggarwal; Pedro M Machado; Jean-Yves Hogrel; Ann M Reed; Lisa Christopher-Stine; Nicolino Ruperto
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

2.  Apremilast in Recalcitrant Cutaneous Dermatomyositis: A Nonrandomized Controlled Trial.

Authors:  Carole Bitar; Thien Ninh; Katherine Brag; Soraya Foutouhi; Stella Radosta; Jade Meyers; Melody Baddoo; Delong Liu; Brittany Stumpf; Paul W Harms; Nakhle S Saba; Erin Boh
Journal:  JAMA Dermatol       Date:  2022-10-05       Impact factor: 11.816

3.  Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy.

Authors:  Hidenori Ichiyasu; Yasumiko Sakamoto; Chieko Yoshida; Kazuhiko Sakamoto; Ryosuke Fujita; Go Nakayama; Hiroko Okabayashi; Sho Saeki; Shinichiro Okamoto; Hirotsugu Kohrogi
Journal:  Respir Med Case Rep       Date:  2016-12-02

4.  Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange.

Authors:  Mizuki Yagishita; Yuya Kondo; Toshihiko Terasaki; Mayu Terasaki; Masaru Shimizu; Fumika Honda; Ayako Oyama; Hiroyuki Takahashi; Masahiro Yokosawa; Hiromitsu Asashima; Shinya Hagiwara; Hiroto Tsuboi; Isao Matsumoto; Takayuki Sumida
Journal:  Intern Med       Date:  2018-02-28       Impact factor: 1.271

5.  Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease:A case report.

Authors:  Hiroyuki Kagawa; Kazuyuki Tsujino; Yuji Yamamoto; Ami Iwai; Reina Hara; Takanori Matsuki; Kiyoharu Fukushima; Yohei Oshitani; Kenji Yoshimura; Mari Miki; Keisuke Miki; Seigo Kitada; Masahide Mori; Hiroshi Kida
Journal:  Respir Med Case Rep       Date:  2020-02-01

6.  The Expression of Cytokine Profiles and Related Receptors in Idiopathic Inflammatory Myopathies.

Authors:  Junyu Zhou; Lijuan Zhao; Yizhi Xiao; Shasha Xie; Ying Long; Yu Wei; Qiming Meng; Xiaojing Li; Hui Luo; Honglin Zhu
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

7.  Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology.

Authors:  Benedict D Michael; Michael J Griffiths; Julia Granerod; David Brown; Nicholas W S Davies; Ray Borrow; Tom Solomon
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.